FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Takedas Entyvio OKd for Crohns Maintenance

FDA approves Takedas Entyvio (vedolizumab) subcutaneous administration for maintenance therapy in adults with moderately to severely active Crohns dis...

latest-news-card-1
Medical Devices

AdvaMed Seeks Clarification on Ethnicity Data in RWE

The Advanced Medical Technology Association says FDAs draft guidance on diversity plans for clinical trials needs to address what sponsors should do i...

latest-news-card-1
Human Drugs

Rinvoq Shows Promise in Arteritis: AbbVie

AbbVie reports positive top-line results from SELECT-GCA, a Phase 3, placebo-controlled study that showed the companys arthritis drug Rinvoq (upadacit...

latest-news-card-1
Human Drugs

Data Show Long-Term Shingrix Efficacy: GSK

GlaxoSmithKline says a follow-up trial of its Shingrix found 80% effectiveness in adults over age 50 up to 11 years after vaccination.

Medical Devices

Philips Respironics Recalls Trilogy Evo Ventilators

Philips Respironics recalls its Trilogy Evo ventilator and all software versions, except 1.05.06.00, due to the devices potential for sudden loss of v...

latest-news-card-1
Human Drugs

FDA Approves Lumisight to Help Find Cancer

FDA approves Lumicells Lumisight to assist in the detection of cancerous tissue in breast cancer patients undergoing a lumpectomy.

latest-news-card-1
Federal Register

Priority Review Voucher to Orchard Therapeutics

Federal Register notice: FDA issues a priority review voucher to Orchard Therapeutics for its rare pediatric disease drug approval for Lenmeldy (atida...

latest-news-card-1
Federal Register

Info Collection on Drug Expedited Programs

Federal Register notice: FDA sends to OMB an information collection extension entitled Expedited Programs for Serious Conditions Drugs and Biologics....

latest-news-card-1
Human Drugs

New PMI Form Explained

CDER Office of Medical Policy regulatory counsel Christopher Diamant explains why the new Patient Medication Information form was developed and how.

latest-news-card-1
Human Drugs

SCOTUS Wont Hear False Labeling Case

Two Polsinelli attorneys say the Supreme Courts refusal to hear an appeal in a labeling case helps manufacturers argue for preemption.